ImmunityBio (IBRX)

ImmunityBio (IBRX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• IBRX last traded at $8.01, -3.38% on the day.
• ImmunityBio: market cap $8.79B, P/E -8.2, revenue $165.79M over the last four quarters, next earnings 2026-11-03.
• Over the past year IBRX returned 239.41%; year to date 304.55%.

Updated 2026-11-02 19:08 UTC